Nisa Investment Advisors’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $926 | Buy |
+941
| New | +$926 | ﹤0.01% | 2750 |
|
|
2025
Q1 | – | Sell |
-973
| Closed | -$2.14K | – | 3011 |
|
|
2024
Q4 | $2.14K | Buy |
973
+430
| +79% | +$946 | ﹤0.01% | 2466 |
|
|
2024
Q3 | $896 | Buy |
+543
| New | +$896 | ﹤0.01% | 2605 |
|
|
2023
Q1 | – | Sell |
-3,800
| Closed | -$24K | – | 2575 |
|
|
2022
Q4 | $24K | Sell |
3,800
-74
| -2% | -$467 | ﹤0.01% | 2009 |
|
|
2022
Q3 | $31K | Buy |
3,874
+74
| +2% | +$592 | ﹤0.01% | 1910 |
|
|
2022
Q2 | $24K | Hold |
3,800
| – | – | ﹤0.01% | 1993 |
|
|
2022
Q1 | $18K | Buy |
+3,800
| New | +$18K | ﹤0.01% | 2074 |
|
|
2021
Q4 | – | Sell |
-405
| Closed | -$5 | – | 2269 |
|
|
2021
Q3 | $5 | Hold |
405
| – | – | ﹤0.01% | 2254 |
|
|
2021
Q2 | $9 | Sell |
405
-2,000
| -83% | -$44 | ﹤0.01% | 2239 |
|
|
2021
Q1 | $67 | Hold |
2,405
| – | – | ﹤0.01% | 1914 |
|
|
2020
Q4 | $63K | Buy |
2,405
+2,150
| +843% | +$56.3K | ﹤0.01% | 1919 |
|
|
2020
Q3 | $9K | Hold |
255
| – | – | ﹤0.01% | 2130 |
|
|
2020
Q2 | $13K | Buy |
255
+55
| +28% | +$2.8K | ﹤0.01% | 1861 |
|
|
2020
Q1 | $6K | Hold |
200
| – | – | ﹤0.01% | 1925 |
|
|
2019
Q4 | $12K | Hold |
200
| – | – | ﹤0.01% | 1796 |
|
|
2019
Q3 | $7K | Buy |
200
+70
| +54% | +$2.45K | ﹤0.01% | 1849 |
|
|
2019
Q2 | $6K | Hold |
130
| – | – | ﹤0.01% | 1858 |
|
|
2019
Q1 | $5K | Hold |
130
| – | – | ﹤0.01% | 1903 |
|
|
2018
Q4 | $6K | Hold |
130
| – | – | ﹤0.01% | 1762 |
|
|
2018
Q3 | $6K | Sell |
130
-130
| -50% | -$6K | ﹤0.01% | 1837 |
|
|
2018
Q2 | $10K | Buy |
260
+110
| +73% | +$4.23K | ﹤0.01% | 1736 |
|
|
2018
Q1 | $11K | Sell |
150
-100
| -40% | -$7.33K | ﹤0.01% | 1622 |
|
|
2017
Q4 | $16K | Buy |
+250
| New | +$16K | ﹤0.01% | 1598 |
|